Page last updated: 2024-10-31

mirtazapine and Dysarthosis

mirtazapine has been researched along with Dysarthosis in 1 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scholten, P1
Kralt, P1
Jacobs, B1

Other Studies

1 other study available for mirtazapine and Dysarthosis

ArticleYear
Posterior fossa progressive multifocal leukoencephalopathy: first presentation of an unknown autoimmune disease.
    BMJ case reports, 2017, Oct-11, Volume: 2017

    Topics: Adrenergic alpha-Antagonists; Cerebellar Ataxia; Disease Progression; Dysarthria; Fatal Outcome; Hum

2017